Biocartis – Idylla POLE-POLD1 Mutation Assay

The Idylla™ POLE-POLD1 Mutation Assay (RUO)* provides a rapid and reliable solution to close an important gap in oncology research by enabling molecular classification of endometrial cancer samples. Its fully automated solution is capable to detect 99% of the known pathogenic POLE and POLD1 mutations and it demonstrated 98.6% accuracy with 434 endometrial cancer tissue […]

Biocartis – Idylla ThyroidPrint Assay

Idylla™ ThyroidPrint® Assay (RUO)* is a novel RT qPCR-based molecular signature that assesses a gene expression profile. Using a proprietary algorithm, ThyroidPrint provides assessment of indeterminate thyroid nodule cytology, classifying as low or high risk of malignancy.